Page last updated: 2024-10-22

amifostine anhydrous and Cancer of Muscle

amifostine anhydrous has been researched along with Cancer of Muscle in 1 studies

Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.

Research Excerpts

ExcerptRelevanceReference
" Nontumor-bearing control animals were sham treated using the same dosing and surgery schedules."1.31Inhibition of spontaneous metastases formation by amifostine. ( Grdina, DJ; Hunter, N; Kataoka, Y; Milas, L; Murley, JS; Weichselbaum, RR, 2002)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Grdina, DJ1
Kataoka, Y1
Murley, JS1
Hunter, N1
Weichselbaum, RR1
Milas, L1

Other Studies

1 other study available for amifostine anhydrous and Cancer of Muscle

ArticleYear
Inhibition of spontaneous metastases formation by amifostine.
    International journal of cancer, 2002, Jan-10, Volume: 97, Issue:2

    Topics: Amifostine; Angiostatins; Animals; Blotting, Western; Cell Division; Dose-Response Relationship, Dru

2002